Trials / Sponsors / OX2 Therapeutics
OX2 Therapeutics
Industry · 2 registered clinical trials — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | CD200AR-L and Allogeneic Tumor Lysate Vaccine Immunotherapy for Recurrent HGG and Newly Diagnosed DMG/DIPG in Diffuse Midline Glioma, H3 K27M-Mutant, Recurrent High Grade Glioma | Phase 1 | 2024-03-15 |
| Unknown | Study of CD200 Activation Receptor Ligand (CD200AR-L) and Allogeneic Tumor Lysate Vaccine Immunotherapy for Re Glioblastoma | Phase 1 | 2020-12-01 |